Zydus Lifesciences Ltd has received the Establishment Inspection Report (EIR) report from the US FDA for the inspection conducted at its API manufacturing facility located at Ankleshwar. This facility underwent an inspection from 10th to 14th March 2025, and the inspection has been classified as No Action Indicated (NAI). The USFDA has concluded that this inspection is "closed".
Shares of Zydus Lifesciences Limited was last trading in BSE at Rs. 978.75 as compared to the previous close of Rs. 981.60. The total number of shares traded during the day was 33052 in over 1951 trades.
The stock hit an intraday high of Rs. 990.80 and intraday low of 977.25. The net turnover during the day was Rs. 32551628.00.